Affiliation:
1. Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan
2. Research Center for Intestinal Health Science, Okayama University, Okayama, Japan
Abstract
ABSTRACT
The lipopeptide antibiotic daptomycin exhibits bactericidal activity against Gram-positive bacteria by forming a complex with phosphatidylglycerol (PG) and lipid II in the cell membrane, causing membrane perforation. With the emergence of daptomycin-resistant bacteria, understanding the mechanisms of bacterial resistance to daptomycin has gained great importance. In this study, we aimed to identify the genetic factors contributing to daptomycin resistance in
Bacillus subtilis
, a model Gram-positive bacterium. Our findings demonstrated that overexpression of
ugtP
, which encodes diglucosyldiacylglycerol synthase, induces daptomycin resistance in
B. subtilis
. Specifically, overexpression of
ugtP
resulted in increased levels of diglucosyldiacylglycerol (Glc
2
DAG) and decreased levels of acidic phospholipids cardiolipin and PG, as well as the basic phospholipid lysylphosphatidylglycerol. However,
ugtP
overexpression did not alter the cell surface charge and the susceptibility to the cationic antimicrobial peptide nisin or the cationic surfactant hexadecyltrimethylammonium bromide. Furthermore, by serial passaging in the presence of daptomycin, we obtained daptomycin-resistant mutants carrying
ugtP
mutations. These mutants showed increased levels of Glc
2
DAG and a >4-fold increase in the minimum inhibitory concentration of daptomycin. These results suggest that increased Glc
2
DAG levels, driven by
ugtP
overexpression, modify the phospholipid composition and confer daptomycin resistance in
B. subtilis
without altering the cell surface charge of the bacteria.
IMPORTANCE
Daptomycin is one of the last-resort drugs for the treatment of methicillin-resistant
Staphylococcus aureus
infections, and the emergence of daptomycin-resistant bacteria has become a major concern. Understanding the mechanism of daptomycin resistance is important for establishing clinical countermeasures against daptomycin-resistant bacteria. In the present study, we found that overexpression of
ugtP
, which encodes diglucosyldiacylglycerol synthase, induces daptomycin resistance in
B. subtilis
, a model Gram-positive bacteria. The overexpression of
UgtP
increased diglucosyldiacylglycerol levels, resulting in altered phospholipid composition and daptomycin resistance. These findings are important for establishing clinical strategies against daptomycin-resistant bacteria, including their detection and management.
Funder
MEXT | Japan Society for the Promotion of Science
Japan Agency for Medical Research and Development
Takeda Science Foundation
Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care
Ryobi Teien Memory Foundation
Publisher
American Society for Microbiology